Kalyan Handique, Ph.D.

Dr. Kalyan Handique is one of the most prolific biotech and medical device innovators from Michigan with over 400 world wide patents. He is the founder of two successful healthcare start-ups Handylab and Celsee Inc. He currently serves as the Chief Innovation Officer, CDG at BioRad Laboratories. Kalyan joined BioRad through the successful acquisition of Celsee in April 2020. Celsee focused on developing innovative technologies for rare cell and single cell analysis. Before Celsee, Handy was a founder of HandyLab, a molecular diagnostics startup based in Ann Arbor, MI that was sold to Becton Dickinson for $275M in late 2009. He serves as an advisor, mentor and board member to many startups and seed funds in the Michigan Biotech Region. Handy holds a PhD in Chemical Engineering from the University of Michigan.